HRSA is accepting applications for payment from rural health clinics (RHC) and federally qualified health centers (FQHC) employing buprenorphine waivered providers under a new program, the DATA 2000 Waiver Training Payment Program. RHCs and FQHCs have the opportunity to apply for a $3,000 payment for each eligible employed provider who attained a Drug Addiction Treatment Act of 2000 (DATA 2000) waiver on or after January 1, 2019. The program is conducted in collaboration with SAMHSA. Waivers are issued by SAMHSA’s Center for Substance Abuse Treatment (CSAT) and its Center for Behavioral Health Statistics and Quality (CBHSQ) maintains the verified waivered practitioner database. There is no deadline to apply for this payment program, but available funds are limited and will be paid on a first-come, first-served basis. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, Section 6083, made $6 million available to FQHCs and $2 million available to RHCs under the DATA 2000 Waiver Training Payment Program. HRSA will accept applications for payment and process payments until all available funds are exhausted.